Search results
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo News· 9 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
Novartis (NVS) Plans to Spin Off Generics Business Sandoz
Zacks via Yahoo News· 2 years agoNovartis NVS has announced plans to spin off Sandoz, its generics and biosimilars division, into a...
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel...
Zacks via Yahoo News· 8 months agoFor Immediate Release Chicago, IL – October 31, 2023 – Today, Zacks Equity Research discusses Dr....
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance...
Zacks via Yahoo News· 7 months agoFor Immediate Release Chicago, IL – November 21, 2023 – Zacks.com announces the list of stocks...
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO
Zacks via Yahoo News· 2 years agoTeva Pharmaceutical Industries Limited TEVA announced that it has appointed Richard Francis as its...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo News· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...
House Dems press drug companies on nationwide shortages
The Hill via Yahoo News· 4 months agoHouse Oversight Democrats are pressing pharmaceutical companies on the nationwide shortages of a...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo News· 12 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Zacks via Yahoo News· 3 months agoBausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced...
Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision
Zacks via Yahoo News· 2 years agoBausch Health Companies Inc. BHC has announced that it will appeal to the U.S. Court of Appeals for...